Based on the SMILES representation OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO, the molecule has a half life in humans after IV administration of 2.300 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol